4930434E21Rik Inhibitors

The chemical class referred to as Wdr95 Inhibitors would comprise compounds that indirectly affect the function of Wdr95 by modulating various cellular mechanisms and signaling pathways. Withaferin A, for instance, is known to disrupt protein-protein interactions, which can affect the assembly of protein complexes involving Wdr95. Geldanamycin, by binding to Hsp90, could destabilize client proteins, including those with WD40 domains, thus altering the functional state of Wdr95. Compounds like curcumin have broad effects on cellular signaling, which can change the activity or stability of Wdr95 within those pathways.

On the other hand, ivermectin and rifampicin, by their respective mechanisms, can perturb protein-ligand interactions or protein synthesis, which in turn can have implications for the functionality of Wdr95. Chlorpromazine's diverse effects could also lead to altered Wdr95 activity. U-0126 and LY294002 target specific kinases within critical signaling pathways, and by such means, can exert influence over Wdr95's role in these pathways. Trichostatin A and MG-132 operate by modulating gene expression and protein turnover, respectively, and could thereby affect the expression levels or degradation of Wdr95. Rapamycin and Wnt-C59 alter growth and signaling pathways, where Wdr95 may participate, thus potentially affecting its activity or expression.